Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 2001 Apr;38(4):234–237. doi: 10.1136/jmg.38.4.234

A polymorphism in the gene for microsomal epoxide hydrolase is associated with pre-eclampsia

P Zusterzeel 1, W Peters 1, W Visser 1, K Hermsen 1, H Roelofs 1, E Steegers 1
PMCID: PMC1734856  PMID: 11283205

Abstract

OBJECTIVE—Microsomal epoxide hydrolase is an important enzyme involved in the metabolism of endogenous and exogenous toxicants. Polymorphic variants of the human epoxide hydrolase gene vary in enzyme activity. We determined whether genetic variability in the gene encoding for microsomal epoxide hydrolase contributes to individual differences in susceptibility to the development of pre-eclampsia with or without the syndrome of Haemolysis, Elevated Liver enzymes, and Low Platelets (HELLP).
METHODS—A total of 183 non-pregnant women with a history of pre-eclampsia, 96 of whom had concurrently developed the HELLP syndrome, and 151 healthy female controls were genotyped for the 113Tyr→His polymorphism in exon 3 and the 139His→Arg polymorphism in exon 4 of the epoxide hydrolase gene by a polymerase chain reaction-restriction fragment length polymorphism assay. Chi-square analysis was used for statistical evaluation of differences in polymorphic rates.
RESULTS—In pre-eclampsia a higher frequency (29%) of the high activity genotype Tyr113 Tyr113 in exon 3 was found as compared to controls (16%, OR 2.0, 95% CI 1.2-3.7). There was no difference between groups for the 139His→Arg polymorphism. In women with a history of pre-eclampsia, no difference in epoxide hydrolase genotypes was found between women who either did or did not develop the HELLP syndrome. In addition, a significant association was found between predicted EPHX activity and pre-eclampsia.
CONCLUSIONS—Women with the high activity genotype in exon 3, which could reflect differences in metabolic activation of endogenous or exogenous toxic compounds, may have enhanced susceptibility to pre-eclampsia. However, polymorphisms in the epoxide hydrolase gene do not seem to influence the risk for concurrent development of the HELLP syndrome.


Keywords: pre-eclampsia; HELLP syndrome; epoxide hydrolase; genetic polymorphism

Full Text

The Full Text of this article is available as a PDF (149.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bartsch H., Hietanen E. The role of individual susceptibility in cancer burden related to environmental exposure. Environ Health Perspect. 1996 May;104 (Suppl 3):569–577. doi: 10.1289/ehp.96104s3569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Benhamou S., Reinikainen M., Bouchardy C., Dayer P., Hirvonen A. Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Res. 1998 Dec 1;58(23):5291–5293. [PubMed] [Google Scholar]
  3. Guengerich F. P., Johnson W. W., Ueng Y. F., Yamazaki H., Shimada T. Involvement of cytochrome P450, glutathione S-transferase, and epoxide hydrolase in the metabolism of aflatoxin B1 and relevance to risk of human liver cancer. Environ Health Perspect. 1996 May;104 (Suppl 3):557–562. doi: 10.1289/ehp.96104s3557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hassett C., Aicher L., Sidhu J. S., Omiecinski C. J. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet. 1994 Mar;3(3):421–428. doi: 10.1093/hmg/3.3.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Higgs G. A., Vane J. R. Inhibition of cyclo-oxygenase and lipoxygenase. Br Med Bull. 1983 Jul;39(3):265–270. doi: 10.1093/oxfordjournals.bmb.a071831. [DOI] [PubMed] [Google Scholar]
  6. Hubel C. A., Kozlov A. V., Kagan V. E., Evans R. W., Davidge S. T., McLaughlin M. K., Roberts J. M. Decreased transferrin and increased transferrin saturation in sera of women with preeclampsia: implications for oxidative stress. Am J Obstet Gynecol. 1996 Sep;175(3 Pt 1):692–700. doi: 10.1053/ob.1996.v175.a74252. [DOI] [PubMed] [Google Scholar]
  7. Kabi B. C., Goel N., Rao Y. N., Tripathy R., Tempe A., Thakur A. S. Levels of erythrocyte malonyldialdehyde, vitamin E, reduced glutathione, G6PD activity & plasma urate in patients of pregnancy induced hypertension. Indian J Med Res. 1994 Jul;100:23–25. [PubMed] [Google Scholar]
  8. Knapen M. F., Zusterzeel P. L., Peters W. H., Steegers E. A. Glutathione and glutathione-related enzymes in reproduction. A review. Eur J Obstet Gynecol Reprod Biol. 1999 Feb;82(2):171–184. doi: 10.1016/s0301-2115(98)00242-5. [DOI] [PubMed] [Google Scholar]
  9. Koymans L., Donné-op den Kelder G. M., Koppele Te J. M., Vermeulen N. P. Cytochromes P450: their active-site structure and mechanism of oxidation. Drug Metab Rev. 1993;25(3):325–387. doi: 10.3109/03602539308993979. [DOI] [PubMed] [Google Scholar]
  10. Lancaster J. M., Brownlee H. A., Bell D. A., Futreal P. A., Marks J. R., Berchuck A., Wiseman R. W., Taylor J. A. Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Mol Carcinog. 1996 Nov;17(3):160–162. doi: 10.1002/(SICI)1098-2744(199611)17:3<160::AID-MC8>3.0.CO;2-J. [DOI] [PubMed] [Google Scholar]
  11. McGlynn K. A., Rosvold E. A., Lustbader E. D., Hu Y., Clapper M. L., Zhou T., Wild C. P., Xia X. L., Baffoe-Bonnie A., Ofori-Adjei D. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2384–2387. doi: 10.1073/pnas.92.6.2384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Omiecinski C. J., Aicher L., Swenson L. Developmental expression of human microsomal epoxide hydrolase. J Pharmacol Exp Ther. 1994 Apr;269(1):417–423. [PubMed] [Google Scholar]
  13. Salama S. A., Sierra-Torres C. H., Oh H. Y., Hamada F. A., Au W. W. A multiplex-PCR/RFLP procedure for simultaneous CYP2E1, mEH and GSTM1 genotyping. Cancer Lett. 1999 Aug 23;143(1):51–56. doi: 10.1016/s0304-3835(99)00192-5. [DOI] [PubMed] [Google Scholar]
  14. Seidegård J., DePierre J. W. Microsomal epoxide hydrolase. Properties, regulation and function. Biochim Biophys Acta. 1983 Dec 29;695(3-4):251–270. doi: 10.1016/0304-419x(83)90014-8. [DOI] [PubMed] [Google Scholar]
  15. Seidegård J., Ekström G. The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics. Environ Health Perspect. 1997 Jun;105 (Suppl 4):791–799. doi: 10.1289/ehp.105-1470052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Smith C. A., Harrison D. J. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet. 1997 Aug 30;350(9078):630–633. doi: 10.1016/S0140-6736(96)08061-0. [DOI] [PubMed] [Google Scholar]
  17. Wang X., Wang M., Niu T., Chen C., Xu X. Microsomal epoxide hydrolase polymorphism and risk of spontaneous abortion. Epidemiology. 1998 Sep;9(5):540–544. [PubMed] [Google Scholar]
  18. Wormhoudt L. W., Commandeur J. N., Vermeulen N. P. Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity. Crit Rev Toxicol. 1999 Jan;29(1):59–124. doi: 10.1080/10408449991349186. [DOI] [PubMed] [Google Scholar]
  19. Yang S. K. Stereoselectivity of cytochrome P-450 isozymes and epoxide hydrolase in the metabolism of polycyclic aromatic hydrocarbons. Biochem Pharmacol. 1988 Jan 1;37(1):61–70. doi: 10.1016/0006-2952(88)90755-1. [DOI] [PubMed] [Google Scholar]
  20. Zusterzeel P. L., Visser W., Peters W. H., Merkus H. W., Nelen W. L., Steegers E. A. Polymorphism in the glutathione S-transferase P1 gene and risk for preeclampsia. Obstet Gynecol. 2000 Jul;96(1):50–54. doi: 10.1016/s0029-7844(00)00845-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES